{"id":"https://openalex.org/W4249019972","doi":"https://doi.org/10.1093/ibd/izaa347.007","title":"NANOPARTICLE-ENCAPSULATED BROMODOMAIN-CONTAINING PROTEIN 4 INHIBITORS FOR THERAPEUTICS OF INFLAMMATORY BOWEL DISEASE","display_name":"NANOPARTICLE-ENCAPSULATED BROMODOMAIN-CONTAINING PROTEIN 4 INHIBITORS FOR THERAPEUTICS OF INFLAMMATORY BOWEL DISEASE","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W4249019972","doi":"https://doi.org/10.1093/ibd/izaa347.007"},"language":"en","primary_location":{"id":"doi:10.1093/ibd/izaa347.007","doi":"https://doi.org/10.1093/ibd/izaa347.007","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izaa347.007","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Mansi Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mansi Shah","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100421520","display_name":"Yi Li","orcid":"https://orcid.org/0000-0002-4543-684X","observed_orcids":["https://orcid.org/0000-0002-4543-684X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Wang Pingyuan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wang Pingyuan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100637456","display_name":"Haiying Chen","orcid":"https://orcid.org/0000-0003-2841-5518","observed_orcids":["https://orcid.org/0000-0003-2841-5518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haiying Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100725253","display_name":"Zhiqing Liu","orcid":"https://orcid.org/0000-0003-0266-6677","observed_orcids":["https://orcid.org/0000-0003-0266-6677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhiqing Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006930837","display_name":"Yingzi Cong","orcid":"https://orcid.org/0000-0003-4167-7395","observed_orcids":["https://orcid.org/0000-0003-4167-7395"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yingzi Cong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Irina Pinchuk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irina Pinchuk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091026624","display_name":"Erik Rytting","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erik Rytting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100684817","display_name":"Jia Zhou","orcid":"https://orcid.org/0000-0001-9292-3838","observed_orcids":["https://orcid.org/0000-0001-9292-3838"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jia Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Bing Tian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bing Tian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3317,"currency":"USD","value_usd":3317},"apc_paid":null,"fwci":0.1414,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.47636258,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"27","issue":"Supplement_1","first_page":"S3","last_page":"S4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.33230000734329224,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0348999984562397,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brd4-inhibitors","display_name":"BRD4 inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/brd4","display_name":"BRD4","score":0.9639999866485596}],"concepts":[{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.6902688145637512},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.6210883259773254},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6150266528129578},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.47865402698516846},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.45790621638298035},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4409516155719757},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4149664640426636},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.39996910095214844},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36392128467559814},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.308840274810791},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.17176392674446106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.163919597864151},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.09087741374969482}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ibd/izaa347.007","doi":"https://doi.org/10.1093/ibd/izaa347.007","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izaa347.007","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4318184347","https://openalex.org/W4236408942","https://openalex.org/W4248881220","https://openalex.org/W4416132240","https://openalex.org/W4409077904","https://openalex.org/W4403629431","https://openalex.org/W4318464523","https://openalex.org/W4408470919","https://openalex.org/W2341452075","https://openalex.org/W2988352267"],"abstract_inverted_index":{"Abstract":[0],"Ulcerative":[1],"Colitis":[2,362,379],"(UC)":[3],"and":[4,23,42,87,99,134,196,200,217,229,262,271,319,369],"Crohn\u2019s":[5,360,377],"disease":[6,15],"(CD),":[7],"the":[8,35,43,94,112,299,376],"two":[9],"major":[10,36],"types":[11],"of":[12,28,45,53,96,108,111,144,171,224,243,293,301,313,343,347,381],"inflammatory":[13],"bowel":[14],"(IBD),":[16],"are":[17],"chronic":[18,29],"diseases":[19],"with":[20,189,213,268],"recurrent":[21],"symptoms":[22],"significant":[24],"morbidity.":[25],"Long-term":[26],"persistence":[27],"inflammation":[30,98,307,339],"in":[31,101,104,116,150,156,210,277,282,308,326,340],"IBD":[32,118,188,310,356,371],"is":[33,120],"among":[34],"factors":[37],"contributing":[38],"to":[39,60,121,124,180],"neoplastic":[40],"transformation":[41],"development":[44],"colitis-associated":[46],"colorectal":[47],"cancer.":[48],"There":[49],"exists":[50],"a":[51,73,197,234,240],"lack":[52],"efficient":[54],"medications":[55],"for":[56,77,187,355],"IBD,":[57],"primarily":[58],"due":[59],"either":[61],"limited":[62],"efficacy":[63,133,158,328],"or":[64,284],"side":[65,136],"effects.":[66,137],"Targeting":[67],"bromodomain-containing":[68],"protein":[69],"4":[70],"(BRD4)":[71],"represents":[72],"novel":[74],"therapeutic":[75,199],"strategy":[76],"IBD.":[78,109,344],"Recently,":[79],"we":[80,139,255],"have":[81,204],"successfully":[82,205],"identified":[83],"proprietary,":[84],"highly":[85],"potent,":[86],"specific":[88,192],"BRD4":[89,147,173,208,225,296,334,349],"inhibitors":[90,148,174,209,226,297,335,350],"which":[91],"significantly":[92,154],"suppressed":[93],"initiation":[95],"mucosal":[97,126],"chronicity":[100],"proof-of-concept":[102],"studies":[103],"several":[105],"animal":[106,311,341],"models":[107,312,342],"One":[110],"most":[113],"pressing":[114],"challenges":[115],"current":[117],"research":[119],"develop":[122],"technologies":[123],"enable":[125],"targeted":[127],"drug":[128],"delivery":[129,143,170,346],"systems":[130],"that":[131,141,164,178,331],"enhance":[132],"decrease":[135],"Intriguingly,":[138],"found":[140],"local":[142],"our":[145,207,294,324,332],"first-generation":[146],"encapsulated":[149,206,232],"nanoparticles":[151,177,212],"can":[152],"achieve":[153],"higher":[155,190],"vivo":[157,327],"at":[159,287,298],"much":[160],"lower":[161],"doses":[162],"than":[163],"attained":[165],"by":[166,175,233],"systemic":[167],"administration.":[168],"Local":[169,345],"nanoparticle-encapsulated":[172,348],"designing":[176],"bind":[179],"inflamed":[181],"epithelium":[182],"would":[183],"offer":[184,352],"superior":[185,353],"pharmacotherapy":[186,354],"efficacy,":[191],"delivery,":[193],"long-lasting":[194],"release,":[195],"better":[198],"safety":[201],"window.":[202],"We":[203],"biodegradable":[211],"excellent":[214],"encapsulation":[215],"efficiency":[216],"favorable":[218],"particle":[219],"size.":[220],"Our":[221],"new":[222],"generation":[223],"ZL0513,":[227],"ZL0742,":[228],"ZL0591":[230],"were":[231],"modified":[235],"solvent":[236],"displacement":[237],"method":[238],"using":[239],"polymeric":[241],"matrix":[242],"PEGylated":[244],"poly":[245],"(lactic-co-glycolic":[246],"acid)":[247],"(PLGA).":[248],"To":[249],"evaluate":[250],"their":[251],"potential":[252],"cytotoxic":[253],"effects,":[254],"incubated":[256],"human":[257],"colonic":[258,306,338],"epithelial":[259],"cells":[260,266],"(HCECs)":[261],"peripheral":[263],"blood":[264],"mononuclear":[265],"(PBMCs)":[267],"PEGylated-PLGA-ZL0513,":[269],"ZL0591,":[270],"ZL0742":[272],"overnight.":[273],"No":[274],"apparent":[275],"increase":[276],"cell":[278],"death":[279],"was":[280],"detected":[281],"HCECs":[283],"PBMCs":[285],"even":[286],"40":[288],"\u03bcM.":[289],"Furthermore,":[290],"oral":[291],"administration":[292],"nano-encapsulated":[295,333],"dosage":[300],"2":[302],"mg/kg":[303],"effectively":[304,336],"block":[305,337],"both":[309],"dextran":[314],"sulfate":[315],"sodium":[316],"(DSS)-induced":[317],"colitis":[318],"oxazolone":[320],"(OXA)-induced":[321],"colitis.":[322],"Collectively,":[323],"compelling":[325],"data":[329],"support":[330],"may":[351],"patients.":[357],"Funding":[358],"support:":[359],"&":[361,378],"Foundation":[363,380],"Entrepreneurial":[364],"Investing":[365],"(EI)":[366],"Initiative":[367],"award":[368,374],"Litwin":[370],"Pioneers":[372],"Program":[373],"from":[375],"America.":[382]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-05-12T00:00:00"}